AIDA — Aida Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for Aida Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2003 December 31st | R2004 December 31st | C2005 December 31st | C2006 December 31st | 2007 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10KSB | 10KSB | 10KSB | 10KSB | 10KSB |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0 | 2.81 | 3.13 | 7.43 | 19 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | — | 8.11 | 13.7 | 16.9 | 11.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0 | 18.3 | 22.4 | 29.6 | 36.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | — | 3.57 | 12.8 | 14 | 17 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 0 | 25.2 | 42.7 | 53.8 | 62.7 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.017 | 17.3 | 28.3 | 30.7 | 38.9 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.017 | 20.1 | 35.9 | 43.6 | 49.4 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.017 | 5.11 | 6.72 | 10.3 | 13.3 |
| Total Liabilities & Shareholders' Equity | 0 | 25.2 | 42.7 | 53.8 | 62.7 |
| Total Common Shares Outstanding |